Please login to the form below

Not currently logged in
Email:
Password:

Exscientia

This page shows the latest Exscientia news and features for those working in and with pharma, biotech and healthcare.

BMS links up with Exscientia for $1.2bn AI drug discovery deal

BMS links up with Exscientia for $1.2bn AI drug discovery deal

Exscientia’s application of AI technologies is proving capable of generating best-in-class molecules while also reducing discovery times. ... technologies and drug discovery expertise,” said Andrew Hopkins, chief executive officer of Exscientia.

Latest news

More from news
Approximately 6 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • A snapshot of… Exscientia A snapshot of… Exscientia

    At Exscientia, we uniquely apply AI and machine learning with experiments in order to accelerate the discovery of new clinic-ready compounds. ... What impact is the planned Brexit having on the company? For Exscientia, access to great talent is vital.

  • AI and genomics: a revolution in drug discovery and development AI and genomics: a revolution in drug discovery and development

    Likewise, Sanofi has partnered with Exscientia to use its artificial intelligence technology to find potentials targets for metabolic disease therapies.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need...
JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...